Johan Kers
About Johan Kers
Johan Kers is the Co-founder and CEO of Birch Biosciences, with a background in molecular microbiology and expertise in bioinformatics. He has held various leadership roles in companies such as AbSci and Ginkgo Bioworks, and has experience in grant writing and fundraising.
Work at Birch Biosciences
Johan Kers serves as the Co-founder and CEO of Birch Biosciences, a position he has held since 2021. Under his leadership, the company focuses on advancements in synthetic biology and protein engineering. Kers participated in Y Combinator's Summer 2022 batch, which provided valuable resources and networking opportunities to support the growth of Birch Biosciences. His role involves overseeing the strategic direction of the company and fostering innovation within the team.
Previous Experience in Biotechnology
Before his current role, Johan Kers held several significant positions in the biotechnology sector. He worked at AbSci in various capacities, including Director of Molecular Sciences, Chief Technology Officer, and Senior Director of Strategic Partnerships. His tenure at AbSci spanned from 2018 to 2021. Kers also served as Program Director at Joyn Bio and Ginkgo Bioworks, where he contributed to projects in the Greater Boston Area. His experience encompasses a range of roles that highlight his expertise in molecular microbiology and strategic program management.
Educational Background
Johan Kers has a robust educational foundation in the life sciences. He earned a Master of Science in Plant Science from Western University from 1998 to 2001. He then pursued a Ph.D. in Plant Pathology at Cornell University from 2001 to 2005. Following his doctoral studies, Kers completed a post-doctoral fellowship at Stanford University School of Medicine from 2005 to 2011. His academic background has equipped him with a deep understanding of molecular biology and related disciplines.
Expertise in Bioinformatics and Communication
Kers possesses expertise in bioinformatics, which enhances his work in synthetic biology and protein engineering. His skills extend to grant writing, supporting his efforts in fundraising and business development. Additionally, he has a proven ability to translate complex technical subjects for general audiences, improving communication with non-specialists. This skill set is crucial in bridging the gap between scientific research and its practical applications in various industries.